| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_031b407a6c144a91e91831eeb958d415 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-70596
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-136
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2217-05 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-705
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-63
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H21-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01K67-027
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-00 |
| filingDate |
2008-10-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_31fddd3c8358969ed074b20879641ffc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5154d10c5fca6715adf73093e7395915
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_acc08eae0471b02d9f8bb01f1c5c8b21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_800549a204e27992e68f3cb58deeda5d |
| publicationDate |
2009-05-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2009123461-A1 |
| titleOfInvention |
Human podocalyxin alternative-spliced forms and uses thereof |
| abstract |
The present invention provides a method for diagnosing and detecting cancer. The present invention provides one or more proteins or fragments thereof, peptides or nucleic acid molecules differentially expressed in cancer (podocalyxin) and antibodies that bind podocalyxins. The present invention provides that podocalyxins are used as targets for screening agents that modulate podocalyxin activities. Further the present invention provides methods for treating diseases associated with podocalyxin expression. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3060580-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3060580-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11090383-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11390673-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8760960-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015058301-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2012213019-A1 |
| priorityDate |
2006-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |